A citation-based method for searching scientific literature

Marc Maynadié, Roberta De Angelis, Rafael Marcos-Gragera, Otto Visser, Claudia Allemani, Carmen Tereanu, Riccardo Capocaccia, Adriano Giacomin, Jean-Michel Lutz, Carmen Martos, Risto Sankila, Tom Børge Johannesen, Arianna Simonetti, Milena Sant. Haematologica 2013
Times Cited: 51







List of co-cited articles
249 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.
Milena Sant, Claudia Allemani, Carmen Tereanu, Roberta De Angelis, Riccardo Capocaccia, Otto Visser, Rafael Marcos-Gragera, Marc Maynadié, Arianna Simonetti, Jean-Michel Lutz,[...]. Blood 2010
530
25

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.
Dana E Rollison, Nadia Howlader, Martyn T Smith, Sara S Strom, William D Merritt, Lynn A Ries, Brenda K Edwards, Alan F List. Blood 2008
436
21

Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study.
Malin Hultcrantz, Sigurdur Yngvi Kristinsson, Therese M-L Andersson, Ola Landgren, Sandra Eloranta, Asa Rangert Derolf, Paul W Dickman, Magnus Björkholm. J Clin Oncol 2012
144
19

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
Hartmut Döhner, Elihu H Estey, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Alan K Burnett, Hervé Dombret, Pierre Fenaux, David Grimwade, Richard A Larson,[...]. Blood 2010
19

Incidence, survival and prevalence of myeloid malignancies in Europe.
O Visser, A Trama, M Maynadié, C Stiller, R Marcos-Gragera, R De Angelis, S Mallone, C Tereanu, C Allemani, U Ricardi,[...]. Eur J Cancer 2012
131
17

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
James W Vardiman, Jüergen Thiele, Daniel A Arber, Richard D Brunning, Michael J Borowitz, Anna Porwit, Nancy Lee Harris, Michelle M Le Beau, Eva Hellström-Lindberg, Ayalew Tefferi,[...]. Blood 2009
15

Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.
Rafael Marcos-Gragera, Claudia Allemani, Carmen Tereanu, Roberta De Angelis, Riccardo Capocaccia, Marc Maynadie, Stefano Luminari, Stefano Ferretti, Tom Børge Johannesen, Risto Sankila,[...]. Haematologica 2011
51
13


The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
13

Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
Marc Maynadié, François Girodon, Ines Manivet-Janoray, Morgane Mounier, Francine Mugneret, François Bailly, Bernardine Favre, Denis Caillot, Tony Petrella, Michel Flesch,[...]. Haematologica 2011
63
11

Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union.
Odile Moulard, Jyotsna Mehta, Jon Fryzek, Robert Olivares, Usman Iqbal, Ruben A Mesa. Eur J Haematol 2014
117
11

How common are myeloproliferative neoplasms? A systematic review and meta-analysis.
Glen J Titmarsh, Andrew S Duncombe, Mary Frances McMullin, Michael O'Rorke, Ruben Mesa, Frank De Vocht, Sarah Horan, Lin Fritschi, Mike Clarke, Lesley A Anderson. Am J Hematol 2014
104
11

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Milena Sant, Pamela Minicozzi, Morgane Mounier, Lesley A Anderson, Hermann Brenner, Bernd Holleczek, Rafael Marcos-Gragera, Marc Maynadié, Alain Monnereau, Gemma Osca-Gelis,[...]. Lancet Oncol 2014
184
11


Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.
Alain Monnereau, Xavier Troussard, Aurélien Belot, Anne-Valérie Guizard, Anne-Sophie Woronoff, Simona Bara, Bénédicte Lapôtre-Ledoux, Jean Iwaz, Brigitte Tretarre, Marc Maynadié. Int J Cancer 2013
43
11

Improving survival trends in primary myelofibrosis: an international study.
Francisco Cervantes, Brigitte Dupriez, Francesco Passamonti, Alessandro M Vannucchi, Enrica Morra, John T Reilly, Jean-Loup Demory, Elisa Rumi, Paola Guglielmelli, Elisa Roncoroni,[...]. J Clin Oncol 2012
84
9

Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors.
Alexandra P Wolanskyj, Susan M Schwager, Rebecca F McClure, Dirk R Larson, Ayalew Tefferi. Mayo Clin Proc 2006
228
9

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
J Nangalia, C E Massie, E J Baxter, F L Nice, G Gundem, D C Wedge, E Avezov, J Li, K Kollmann, D G Kent,[...]. N Engl J Med 2013
9

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Richard A Larson,[...]. Blood 2017
9

Acute Myeloid Leukemia.
Hartmut Döhner, Daniel J Weisdorf, Clara D Bloomfield. N Engl J Med 2015
9

International scoring system for evaluating prognosis in myelodysplastic syndromes.
P Greenberg, C Cox, M M LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, T Vallespi, T Hamblin, D Oscier,[...]. Blood 1997
7

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Pierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan List,[...]. Lancet Oncol 2009
7

Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia.
Francesco Passamonti, Elisa Rumi, Ester Pungolino, Lucia Malabarba, Paola Bertazzoni, Marina Valentini, Ester Orlandi, Luca Arcaini, Ercole Brusamolino, Cristiana Pascutto,[...]. Am J Med 2004
309
7

A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Robert Kralovics, Francesco Passamonti, Andreas S Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R Passweg, Andre Tichelli, Mario Cazzola, Radek C Skoda. N Engl J Med 2005
7

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).
Francesco Passamonti, Francisco Cervantes, Alessandro Maria Vannucchi, Enrica Morra, Elisa Rumi, Arturo Pereira, Paola Guglielmelli, Ester Pungolino, Marianna Caramella, Margherita Maffioli,[...]. Blood 2010
606
7

Underreporting of myeloid malignancies by United States cancer registries.
Benjamin M Craig, Dana E Rollison, Alan F List, Christopher R Cogle. Cancer Epidemiol Biomarkers Prev 2012
57
7

Standard cancer patient population for age standardising survival ratios.
Isabella Corazziari, Mike Quinn, Riccardo Capocaccia. Eur J Cancer 2004
383
7

Survival patterns in United States (US) medicare enrollees with non-CML myeloproliferative neoplasms (MPN).
Gregory L Price, Keith L Davis, Sudeep Karve, Gerhardt Pohl, Richard A Walgren. PLoS One 2014
37
10


Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in the Iowa Women's Health Study cohort.
Alexis D Leal, Carrie A Thompson, Alice H Wang, Robert A Vierkant, Thomas M Habermann, Julie A Ross, Ruben A Mesa, Beth A Virnig, James R Cerhan. Int J Cancer 2014
37
10

Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades.
Mya S Thein, William B Ershler, Ahmedin Jemal, Jerome W Yates, Maria R Baer. Cancer 2013
133
7

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
Jay P Patel, Mithat Gönen, Maria E Figueroa, Hugo Fernandez, Zhuoxin Sun, Janis Racevskis, Pieter Van Vlierberghe, Igor Dolgalev, Sabrena Thomas, Olga Aminova,[...]. N Engl J Med 2012
7

Age and acute myeloid leukemia.
Frederick R Appelbaum, Holly Gundacker, David R Head, Marilyn L Slovak, Cheryl L Willman, John E Godwin, Jeanne E Anderson, Stephen H Petersdorf. Blood 2006
901
7

Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
Tiziano Barbui, Juergen Thiele, Francesco Passamonti, Elisa Rumi, Emanuela Boveri, Marco Ruggeri, Francesco Rodeghiero, Emanuele S G d'Amore, Maria Luigia Randi, Irene Bertozzi,[...]. J Clin Oncol 2011
308
7

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Claudia Allemani, Hannah K Weir, Helena Carreira, Rhea Harewood, Devon Spika, Xiao-Si Wang, Finian Bannon, Jane V Ahn, Christopher J Johnson, Audrey Bonaventure,[...]. Lancet 2015
7

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.
Eve Roman, Alex Smith, Simon Appleton, Simon Crouch, Richard Kelly, Sally Kinsey, Catherine Cargo, Russell Patmore. Cancer Epidemiol 2016
58
7

Impaired health-related quality of life in acute myeloid leukemia survivors: a single-center study.
Annemieke Leunis, William K Redekop, Carin A Uyl-de Groot, Bob Löwenberg. Eur J Haematol 2014
41
9

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.
Samer A Srour, Susan S Devesa, Lindsay M Morton, David P Check, Rochelle E Curtis, Martha S Linet, Graça M Dores. Br J Haematol 2016
96
7

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.
Hagop Kantarjian, Jean-Pierre J Issa, Craig S Rosenfeld, John M Bennett, Maher Albitar, John DiPersio, Virginia Klimek, James Slack, Carlos de Castro, Farhad Ravandi,[...]. Cancer 2006
5


Myelodysplastic syndromes: incidence and survival in the United States.
Xiaomei Ma, Monique Does, Azra Raza, Susan T Mayne. Cancer 2007
385
5

Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries.
Stuart L Goldberg, Er Chen, Mitra Corral, Amy Guo, Nikita Mody-Patel, Andrew L Pecora, Marianne Laouri. J Clin Oncol 2010
187
5

Revised international prognostic scoring system for myelodysplastic syndromes.
Peter L Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Sanz, Guillermo Garcia-Manero, Francesc Solé, John M Bennett, David Bowen, Pierre Fenaux, Francois Dreyfus,[...]. Blood 2012
5

Unique features of primary myelofibrosis in Chinese.
Zefeng Xu, Robert Peter Gale, Yue Zhang, Tiejun Qin, Huishu Chen, Peihong Zhang, Tianjiao Zhang, Liu Liu, Shiqiang Qu, Zhijian Xiao. Blood 2012
30
10


Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study.
Gemma Gatta, Laura Botta, Silvia Rossi, Tiiu Aareleid, Magdalena Bielska-Lasota, Jacqueline Clavel, Nadya Dimitrova, Zsuzsanna Jakab, Peter Kaatsch, Brigitte Lacour,[...]. Lancet Oncol 2014
568
5

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.
Lindsay M Morton, Sophia S Wang, Susan S Devesa, Patricia Hartge, Dennis D Weisenburger, Martha S Linet. Blood 2006
5

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
Roberta De Angelis, Milena Sant, Michel P Coleman, Silvia Francisci, Paolo Baili, Daniela Pierannunzio, Annalisa Trama, Otto Visser, Hermann Brenner, Eva Ardanaz,[...]. Lancet Oncol 2014
5

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
Brian J Druker, François Guilhot, Stephen G O'Brien, Insa Gathmann, Hagop Kantarjian, Norbert Gattermann, Michael W N Deininger, Richard T Silver, John M Goldman, Richard M Stone,[...]. N Engl J Med 2006
5

Regression models for relative survival.
Paul W Dickman, Andy Sloggett, Michael Hills, Timo Hakulinen. Stat Med 2004
607
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.